ASX:PGC

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. More Details


Snowflake Analysis

Imperfect balance sheet and overvalued.

Share Price & News

How has Paragon Care's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PGC has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

5.4%

PGC

-0.4%

AU Healthcare

-0.5%

AU Market


1 Year Return

-52.4%

PGC

5.1%

AU Healthcare

-6.2%

AU Market

Return vs Industry: PGC underperformed the Australian Healthcare industry which returned 4% over the past year.

Return vs Market: PGC underperformed the Australian Market which returned -5.4% over the past year.


Shareholder returns

PGCIndustryMarket
7 Day5.4%-0.4%-0.5%
30 Day14.7%3.9%6.8%
90 Day11.4%8.3%4.4%
1 Year-52.4%-52.4%7.1%5.1%-2.9%-6.2%
3 Year-75.9%-77.7%21.7%12.0%17.9%2.9%
5 Year-62.7%-67.8%30.3%12.5%43.9%14.6%

Price Volatility Vs. Market

How volatile is Paragon Care's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Paragon Care undervalued compared to its fair value and its price relative to the market?

0.59x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate PGC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate PGC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: PGC is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average.

PE vs Market: PGC is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate PGC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PGC is good value based on its PB Ratio (0.6x) compared to the AU Healthcare industry average (1.4x).


Next Steps

Future Growth

How is Paragon Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Paragon Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Paragon Care performed over the past 5 years?

-30.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PGC is currently unprofitable.

Growing Profit Margin: PGC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: PGC is unprofitable, and losses have increased over the past 5 years at a rate of 30.9% per year.

Accelerating Growth: Unable to compare PGC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PGC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-6.1%).


Return on Equity

High ROE: PGC has a negative Return on Equity (-63.77%), as it is currently unprofitable.


Next Steps

Financial Health

How is Paragon Care's financial position?


Financial Position Analysis

Short Term Liabilities: PGC's short term assets (A$106.3M) exceed its short term liabilities (A$84.9M).

Long Term Liabilities: PGC's short term assets (A$106.3M) exceed its long term liabilities (A$95.0M).


Debt to Equity History and Analysis

Debt Level: PGC's debt to equity ratio (91.2%) is considered high.

Reducing Debt: PGC's debt to equity ratio has increased from 55.9% to 91.2% over the past 5 years.

Debt Coverage: PGC's debt is not well covered by operating cash flow (5.2%).

Interest Coverage: PGC is unprofitable, therefore interest payments are not well covered by earnings.


Balance Sheet


Next Steps

Dividend

What is Paragon Care current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PGC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PGC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PGC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PGC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: PGC is not paying a notable dividend for the Australian market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PGC's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.9yrs

Average management tenure


CEO

Phil Nicholl

0.92

Tenure

AU$440,883

Compensation

Mr. Phil Nicholl, BBus (CSU) serves as Chief Executive Officer at Paragon Care Limited since November 27, 2019 and served as its Head of Device Division. Mr. Nicholl is the Chief Executive Officer of one o ...


CEO Compensation Analysis

Compensation vs Market: Phil's total compensation ($USD313.81K) is about average for companies of similar size in the Australian market ($USD274.65K).

Compensation vs Earnings: Insufficient data to compare Phil's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Phil Nicholl
Chief Executive Officer0.92yrAU$440.88k0.52%
A$ 352.9k
Stephen Munday
Chief Financial Officer0.83yrAU$229.12kno data
Melanie Jaye Leydin
Company Secretaryno datano datano data
Michael Rice
Group Commercial Manager2.42yrsAU$304.03kno data

0.9yrs

Average Tenure

47yo

Average Age

Experienced Management: PGC's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Shane Tanner
Independent Non-Executive Chairman10.42yrsAU$111.00k0.25%
A$ 170.0k
Geoffrey Sam
Non-Executive Independent Director4.33yrsAU$83.24k0.51%
A$ 347.3k
Brent Stewart
Independent Non-Executive Director2.42yrsAU$55.50k0.88%
A$ 596.7k
Mark Simari
Non-Executive Director0.92yrAU$30.50k0.084%
A$ 57.1k

3.4yrs

Average Tenure

66yo

Average Age

Experienced Board: PGC's board of directors are considered experienced (3.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Paragon Care Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Paragon Care Limited
  • Ticker: PGC
  • Exchange: ASX
  • Founded: 1994
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: AU$67.577m
  • Shares outstanding: 337.89m
  • Website: https://www.paragoncare.com.au

Number of Employees


Location

  • Paragon Care Limited
  • 96-100 Albert Road
  • Level 4
  • Melbourne
  • Victoria
  • 3168
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PXSDB (Deutsche Boerse AG)YesOrdinary SharesDEEUROct 1999
PGCASX (Australian Securities Exchange)YesOrdinary SharesAUAUDOct 1999
PGCCHIA (Chi-X Australia)YesOrdinary SharesAUAUDOct 1999

Biography

Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/22 10:37
End of Day Share Price2020/10/22 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.